"U.S. Legislation Threatens Drug Supply Chain and Biotech Firms"

Lawmakers are scrutinizing WuXi AppTec, a major Chinese company, over potential ties to the Chinese government, which has raised concerns about the U.S. supply chain for key drugs. The company is deeply involved in the development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V., and other illnesses, and its potential disconnection from U.S. pharmaceutical interests has rattled the biotech industry. Despite its significant role in the U.S. medicine chest, the Congressional spotlight on the company has led to discussions about potential national security threats and the impact of severing ties with the company.